"Protein-Tyrosine Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.
Descriptor ID |
D011505
|
MeSH Number(s) |
D08.811.913.696.620.682.725
|
Concept/Terms |
Protein-Tyrosine Kinases- Protein-Tyrosine Kinases
- Kinases, Protein-Tyrosine
- Protein Tyrosine Kinases
- Tyrosine Kinase
- Kinase, Tyrosine
- Tyrosine Protein Kinase
- Kinase, Tyrosine Protein
- Tyrosylprotein Kinase
- Kinase, Tyrosylprotein
- Tyrosine-Specific Protein Kinase
- Kinase, Tyrosine-Specific Protein
- Protein Kinase, Tyrosine-Specific
- Tyrosine Specific Protein Kinase
- Tyrosine-Specific Protein Kinases
- Kinases, Tyrosine-Specific Protein
- Protein Kinases, Tyrosine-Specific
- Tyrosine Specific Protein Kinases
- Protein-Tyrosine Kinase
- Kinase, Protein-Tyrosine
- Protein Tyrosine Kinase
- Tyrosine Protein Kinases
- Kinases, Tyrosine Protein
- Protein Kinases, Tyrosine
|
Below are MeSH descriptors whose meaning is more general than "Protein-Tyrosine Kinases".
Below are MeSH descriptors whose meaning is more specific than "Protein-Tyrosine Kinases".
This graph shows the total number of publications written about "Protein-Tyrosine Kinases" by people in this website by year, and whether "Protein-Tyrosine Kinases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 12 | 4 | 16 |
1995 | 14 | 13 | 27 |
1996 | 16 | 7 | 23 |
1997 | 11 | 11 | 22 |
1998 | 15 | 8 | 23 |
1999 | 14 | 9 | 23 |
2000 | 10 | 10 | 20 |
2001 | 19 | 5 | 24 |
2002 | 15 | 16 | 31 |
2003 | 19 | 32 | 51 |
2004 | 17 | 31 | 48 |
2005 | 28 | 22 | 50 |
2006 | 24 | 23 | 47 |
2007 | 20 | 22 | 42 |
2008 | 20 | 11 | 31 |
2009 | 15 | 18 | 33 |
2010 | 25 | 13 | 38 |
2011 | 29 | 18 | 47 |
2012 | 21 | 15 | 36 |
2013 | 21 | 11 | 32 |
2014 | 18 | 5 | 23 |
2015 | 23 | 13 | 36 |
2016 | 14 | 12 | 26 |
2017 | 12 | 16 | 28 |
2018 | 7 | 3 | 10 |
2019 | 7 | 6 | 13 |
2020 | 6 | 7 | 13 |
2021 | 9 | 5 | 14 |
2022 | 0 | 6 | 6 |
2023 | 3 | 8 | 11 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Protein-Tyrosine Kinases" by people in Profiles.
-
2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation. Radiographics. 2024 Mar; 44(3):e230136.
-
Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification. BMC Cancer. 2024 Jan 31; 24(1):155.
-
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA Netw Open. 2023 Dec 01; 6(12):e2347700.
-
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma. Blood Cancer J. 2023 10 12; 13(1):156.
-
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in?situ hybridization. Cancer Cytopathol. 2024 Jan; 132(1):41-49.
-
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition. Leuk Lymphoma. 2023 12; 64(12):2047-2050.
-
Oocyte-specific Wee1-like protein kinase 2 is dispensable for fertility in mice. PLoS One. 2023; 18(8):e0289083.
-
Combined immunodeficiency caused by pathogenic variants in the ZAP70 C-terminal SH2 domain. Front Immunol. 2023; 14:1155883.
-
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. Cancer. 2023 07 15; 129(14):2245-2255.
-
Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center. Leuk Lymphoma. 2023 05; 64(5):1050-1053.